XML 40 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Stockholders' Equity (Details Textual)
6 Months Ended
Jun. 17, 2017
Jan. 01, 2017
shares
Feb. 12, 2016
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2016
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number       2,613,299   2,484,445
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $       $ 193,687   $ 171,537
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       150,000    
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price | $ / shares       $ 1.05   $ 1.02
Class of Warrant or Right Outstanding, Aggregate Intrinsic Value | $       $ 763,342    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares       $ 1.25    
Class of Warrant or Right, Outstanding       3,726,658   3,826,658
Private Placement [Member] | Series B Preferred Stock [Member]            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.25      
Class of Warrant or Right, Expiration Period     5 years      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     423,291      
Protagenic Therapeutics Inc [Member]            
Business Combination, Stock Warrant Conversion Ratio     1      
Debt Instrument, Face Amount | $     $ 665,000      
Debt Instrument, Increase, Accrued Interest | $     $ 35,000      
Protagenic Therapeutics Inc [Member] | Predecessor Warrants [Member]            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.25      
Class of Warrant or Right, Expiration Period     5 years      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     295,945      
Protagenic Therapeutics Inc [Member] | Placement Agent Warrants [Member]            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.25      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     127,346      
Protagenic Therapeutics Inc [Member] | Private Placement [Member]            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.05      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     3,403,367      
Employee Stock Option [Member]            
Allocated Share-based Compensation Expense | $       $ 500,877 $ 176,892  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | $       $ 1,033,921    
The 2016 Plan [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized   564,378        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   2,712,678        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       150,000 1,201,084  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares       $ 1.25 $ 1.25  
The 2006 Plan [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       0 100,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares       $ 1.25 $ 1.25